Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control
Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been shown to modulate HCMV replication. Host-derived cellular pathways can provide an unfavorable environment for virus replication. These pathway...
Saved in:
| Published in | Journal of virology Vol. 97; no. 4; p. e0016023 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Society for Microbiology
27.04.2023
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0022-538X 1098-5514 1098-5514 |
| DOI | 10.1128/jvi.00160-23 |
Cover
Loading…
| Abstract | Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been shown to modulate HCMV replication.
Host-derived cellular pathways can provide an unfavorable environment for virus replication. These pathways have been a subject of interest for herpesviruses, including the betaherpesvirus human cytomegalovirus (HCMV). Here, we demonstrate that a compound, ARP101, induces the noncanonical sequestosome 1 (SQSTM1)/p62-Keap1-Nrf2 pathway for HCMV suppression. ARP101 increased the levels of both LC3 II and SQSTM1/p62 and induced phosphorylation of p62 at the C-terminal domain, resulting in its increased affinity for Keap1. ARP101 treatment resulted in Nrf2 stabilization and translocation into the nucleus, binding to specific promoter sites and transcription of antioxidant enzymes under the antioxidant response element (ARE), and HCMV suppression. Knockdown of Nrf2 recovered HCMV replication following ARP101 treatment, indicating the role of the Keap1-Nrf2 axis in HCMV inhibition by ARP101. SQSTM1/p62 phosphorylation was not modulated by the mTOR kinase or casein kinase 1 or 2, indicating ARP101 engages other kinases. Together, the data uncover a novel antiviral strategy for SQSTM1/p62 through the noncanonical Keap1-Nrf2 axis. This pathway could be further exploited, including the identification of the responsible kinases, to define the biological events during HCMV replication.
IMPORTANCE
Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been shown to modulate HCMV replication. The autophagy receptor sequestosome 1 (SQSTM1)/p62 has been reported to interact with several HCMV proteins, particularly with components of HCMV capsid, suggesting it plays a role in viral replication. Here, we report on a new and unexpected role for SQSTM1/p62, in HCMV suppression. Using a small-molecule probe, ARP101, we show SQSTM1/p62 phosphorylation at its C terminus domain initiates the noncanonical Keap1-Nrf2 axis, leading to transcription of genes under the antioxidant response element, resulting in HCMV inhibition
in vitro.
Our study highlights the dynamic nature of SQSTM1/p62 during HCMV infection and how its phosphorylation activates a new pathway that can be exploited for antiviral intervention. |
|---|---|
| AbstractList | Host-derived cellular pathways can provide an unfavorable environment for virus replication. These pathways have been a subject of interest for herpesviruses, including the betaherpesvirus human cytomegalovirus (HCMV). Here, we demonstrate that a compound, ARP101, induces the noncanonical sequestosome 1 (SQSTM1)/p62-Keap1-Nrf2 pathway for HCMV suppression. ARP101 increased the levels of both LC3 II and SQSTM1/p62 and induced phosphorylation of p62 at the C-terminal domain, resulting in its increased affinity for Keap1. ARP101 treatment resulted in Nrf2 stabilization and translocation into the nucleus, binding to specific promoter sites and transcription of antioxidant enzymes under the antioxidant response element (ARE), and HCMV suppression. Knockdown of Nrf2 recovered HCMV replication following ARP101 treatment, indicating the role of the Keap1-Nrf2 axis in HCMV inhibition by ARP101. SQSTM1/p62 phosphorylation was not modulated by the mTOR kinase or casein kinase 1 or 2, indicating ARP101 engages other kinases. Together, the data uncover a novel antiviral strategy for SQSTM1/p62 through the noncanonical Keap1-Nrf2 axis. This pathway could be further exploited, including the identification of the responsible kinases, to define the biological events during HCMV replication.
IMPORTANCE
Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been shown to modulate HCMV replication. The autophagy receptor sequestosome 1 (SQSTM1)/p62 has been reported to interact with several HCMV proteins, particularly with components of HCMV capsid, suggesting it plays a role in viral replication. Here, we report on a new and unexpected role for SQSTM1/p62, in HCMV suppression. Using a small-molecule probe, ARP101, we show SQSTM1/p62 phosphorylation at its C terminus domain initiates the noncanonical Keap1-Nrf2 axis, leading to transcription of genes under the antioxidant response element, resulting in HCMV inhibition
in vitro.
Our study highlights the dynamic nature of SQSTM1/p62 during HCMV infection and how its phosphorylation activates a new pathway that can be exploited for antiviral intervention. Host-derived cellular pathways can provide an unfavorable environment for virus replication. These pathways have been a subject of interest for herpesviruses, including the betaherpesvirus human cytomegalovirus (HCMV). Here, we demonstrate that a compound, ARP101, induces the noncanonical sequestosome 1 (SQSTM1)/p62-Keap1-Nrf2 pathway for HCMV suppression. ARP101 increased the levels of both LC3 II and SQSTM1/p62 and induced phosphorylation of p62 at the C-terminal domain, resulting in its increased affinity for Keap1. ARP101 treatment resulted in Nrf2 stabilization and translocation into the nucleus, binding to specific promoter sites and transcription of antioxidant enzymes under the antioxidant response element (ARE), and HCMV suppression. Knockdown of Nrf2 recovered HCMV replication following ARP101 treatment, indicating the role of the Keap1-Nrf2 axis in HCMV inhibition by ARP101. SQSTM1/p62 phosphorylation was not modulated by the mTOR kinase or casein kinase 1 or 2, indicating ARP101 engages other kinases. Together, the data uncover a novel antiviral strategy for SQSTM1/p62 through the noncanonical Keap1-Nrf2 axis. This pathway could be further exploited, including the identification of the responsible kinases, to define the biological events during HCMV replication. Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been shown to modulate HCMV replication. The autophagy receptor sequestosome 1 (SQSTM1)/p62 has been reported to interact with several HCMV proteins, particularly with components of HCMV capsid, suggesting it plays a role in viral replication. Here, we report on a new and unexpected role for SQSTM1/p62, in HCMV suppression. Using a small-molecule probe, ARP101, we show SQSTM1/p62 phosphorylation at its C terminus domain initiates the noncanonical Keap1-Nrf2 axis, leading to transcription of genes under the antioxidant response element, resulting in HCMV inhibition Our study highlights the dynamic nature of SQSTM1/p62 during HCMV infection and how its phosphorylation activates a new pathway that can be exploited for antiviral intervention. Host-derived cellular pathways can provide an unfavorable environment for virus replication. These pathways have been a subject of interest for herpesviruses, including the betaherpesvirus human cytomegalovirus (HCMV). Here, we demonstrate that a compound, ARP101, induces the noncanonical sequestosome 1 (SQSTM1)/p62-Keap1-Nrf2 pathway for HCMV suppression. ARP101 increased the levels of both LC3 II and SQSTM1/p62 and induced phosphorylation of p62 at the C-terminal domain, resulting in its increased affinity for Keap1. ARP101 treatment resulted in Nrf2 stabilization and translocation into the nucleus, binding to specific promoter sites and transcription of antioxidant enzymes under the antioxidant response element (ARE), and HCMV suppression. Knockdown of Nrf2 recovered HCMV replication following ARP101 treatment, indicating the role of the Keap1-Nrf2 axis in HCMV inhibition by ARP101. SQSTM1/p62 phosphorylation was not modulated by the mTOR kinase or casein kinase 1 or 2, indicating ARP101 engages other kinases. Together, the data uncover a novel antiviral strategy for SQSTM1/p62 through the noncanonical Keap1-Nrf2 axis. This pathway could be further exploited, including the identification of the responsible kinases, to define the biological events during HCMV replication. IMPORTANCE Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been shown to modulate HCMV replication. The autophagy receptor sequestosome 1 (SQSTM1)/p62 has been reported to interact with several HCMV proteins, particularly with components of HCMV capsid, suggesting it plays a role in viral replication. Here, we report on a new and unexpected role for SQSTM1/p62, in HCMV suppression. Using a small-molecule probe, ARP101, we show SQSTM1/p62 phosphorylation at its C terminus domain initiates the noncanonical Keap1-Nrf2 axis, leading to transcription of genes under the antioxidant response element, resulting in HCMV inhibition in vitro. Our study highlights the dynamic nature of SQSTM1/p62 during HCMV infection and how its phosphorylation activates a new pathway that can be exploited for antiviral intervention.Host-derived cellular pathways can provide an unfavorable environment for virus replication. These pathways have been a subject of interest for herpesviruses, including the betaherpesvirus human cytomegalovirus (HCMV). Here, we demonstrate that a compound, ARP101, induces the noncanonical sequestosome 1 (SQSTM1)/p62-Keap1-Nrf2 pathway for HCMV suppression. ARP101 increased the levels of both LC3 II and SQSTM1/p62 and induced phosphorylation of p62 at the C-terminal domain, resulting in its increased affinity for Keap1. ARP101 treatment resulted in Nrf2 stabilization and translocation into the nucleus, binding to specific promoter sites and transcription of antioxidant enzymes under the antioxidant response element (ARE), and HCMV suppression. Knockdown of Nrf2 recovered HCMV replication following ARP101 treatment, indicating the role of the Keap1-Nrf2 axis in HCMV inhibition by ARP101. SQSTM1/p62 phosphorylation was not modulated by the mTOR kinase or casein kinase 1 or 2, indicating ARP101 engages other kinases. Together, the data uncover a novel antiviral strategy for SQSTM1/p62 through the noncanonical Keap1-Nrf2 axis. This pathway could be further exploited, including the identification of the responsible kinases, to define the biological events during HCMV replication. IMPORTANCE Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been shown to modulate HCMV replication. The autophagy receptor sequestosome 1 (SQSTM1)/p62 has been reported to interact with several HCMV proteins, particularly with components of HCMV capsid, suggesting it plays a role in viral replication. Here, we report on a new and unexpected role for SQSTM1/p62, in HCMV suppression. Using a small-molecule probe, ARP101, we show SQSTM1/p62 phosphorylation at its C terminus domain initiates the noncanonical Keap1-Nrf2 axis, leading to transcription of genes under the antioxidant response element, resulting in HCMV inhibition in vitro. Our study highlights the dynamic nature of SQSTM1/p62 during HCMV infection and how its phosphorylation activates a new pathway that can be exploited for antiviral intervention. Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been shown to modulate HCMV replication. Host-derived cellular pathways can provide an unfavorable environment for virus replication. These pathways have been a subject of interest for herpesviruses, including the betaherpesvirus human cytomegalovirus (HCMV). Here, we demonstrate that a compound, ARP101, induces the noncanonical sequestosome 1 (SQSTM1)/p62-Keap1-Nrf2 pathway for HCMV suppression. ARP101 increased the levels of both LC3 II and SQSTM1/p62 and induced phosphorylation of p62 at the C-terminal domain, resulting in its increased affinity for Keap1. ARP101 treatment resulted in Nrf2 stabilization and translocation into the nucleus, binding to specific promoter sites and transcription of antioxidant enzymes under the antioxidant response element (ARE), and HCMV suppression. Knockdown of Nrf2 recovered HCMV replication following ARP101 treatment, indicating the role of the Keap1-Nrf2 axis in HCMV inhibition by ARP101. SQSTM1/p62 phosphorylation was not modulated by the mTOR kinase or casein kinase 1 or 2, indicating ARP101 engages other kinases. Together, the data uncover a novel antiviral strategy for SQSTM1/p62 through the noncanonical Keap1-Nrf2 axis. This pathway could be further exploited, including the identification of the responsible kinases, to define the biological events during HCMV replication. IMPORTANCE Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been shown to modulate HCMV replication. The autophagy receptor sequestosome 1 (SQSTM1)/p62 has been reported to interact with several HCMV proteins, particularly with components of HCMV capsid, suggesting it plays a role in viral replication. Here, we report on a new and unexpected role for SQSTM1/p62, in HCMV suppression. Using a small-molecule probe, ARP101, we show SQSTM1/p62 phosphorylation at its C terminus domain initiates the noncanonical Keap1-Nrf2 axis, leading to transcription of genes under the antioxidant response element, resulting in HCMV inhibition in vitro. Our study highlights the dynamic nature of SQSTM1/p62 during HCMV infection and how its phosphorylation activates a new pathway that can be exploited for antiviral intervention. Host-derived cellular pathways can provide an unfavorable environment for virus replication. These pathways have been a subject of interest for herpesviruses, including the betaherpesvirus human cytomegalovirus (HCMV). Here, we demonstrate that a compound, ARP101, induces the noncanonical sequestosome 1 (SQSTM1)/p62-Keap1-Nrf2 pathway for HCMV suppression. ARP101 increased the levels of both LC3 II and SQSTM1/p62 and induced phosphorylation of p62 at the C-terminal domain, resulting in its increased affinity for Keap1. ARP101 treatment resulted in Nrf2 stabilization and translocation into the nucleus, binding to specific promoter sites and transcription of antioxidant enzymes under the antioxidant response element (ARE), and HCMV suppression. Knockdown of Nrf2 recovered HCMV replication following ARP101 treatment, indicating the role of the Keap1-Nrf2 axis in HCMV inhibition by ARP101. SQSTM1/p62 phosphorylation was not modulated by the mTOR kinase or casein kinase 1 or 2, indicating ARP101 engages other kinases. Together, the data uncover a novel antiviral strategy for SQSTM1/p62 through the noncanonical Keap1-Nrf2 axis. This pathway could be further exploited, including the identification of the responsible kinases, to define the biological events during HCMV replication. IMPORTANCE Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been shown to modulate HCMV replication. The autophagy receptor sequestosome 1 (SQSTM1)/p62 has been reported to interact with several HCMV proteins, particularly with components of HCMV capsid, suggesting it plays a role in viral replication. Here, we report on a new and unexpected role for SQSTM1/p62, in HCMV suppression. Using a small-molecule probe, ARP101, we show SQSTM1/p62 phosphorylation at its C terminus domain initiates the noncanonical Keap1-Nrf2 axis, leading to transcription of genes under the antioxidant response element, resulting in HCMV inhibition in vitro. Our study highlights the dynamic nature of SQSTM1/p62 during HCMV infection and how its phosphorylation activates a new pathway that can be exploited for antiviral intervention. |
| Author | Ferrer, Marc Smith, Brian C. Forman, Michael Keyes, Robert F. Su, Yu-Pin Arav-Boger, Ravit Ghosh, Ayan K. Hu, Xin |
| Author_xml | – sequence: 1 givenname: Ayan K. surname: Ghosh fullname: Ghosh, Ayan K. organization: Department of Pediatrics, Division of Infectious Disease, Medical College of Wisconsin, Milwaukee, Wisconsin, USA – sequence: 2 givenname: Yu-Pin surname: Su fullname: Su, Yu-Pin organization: Department of Pediatrics, Division of Infectious Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 3 givenname: Michael surname: Forman fullname: Forman, Michael organization: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 4 givenname: Robert F. surname: Keyes fullname: Keyes, Robert F. organization: Department of Biochemistry, Program in Chemical Biology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA – sequence: 5 givenname: Brian C. surname: Smith fullname: Smith, Brian C. organization: Department of Biochemistry, Program in Chemical Biology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA – sequence: 6 givenname: Xin surname: Hu fullname: Hu, Xin organization: National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Rockville, Maryland, USA – sequence: 7 givenname: Marc surname: Ferrer fullname: Ferrer, Marc organization: National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Rockville, Maryland, USA – sequence: 8 givenname: Ravit orcidid: 0000-0002-5363-167X surname: Arav-Boger fullname: Arav-Boger, Ravit organization: Department of Pediatrics, Division of Infectious Disease, Medical College of Wisconsin, Milwaukee, Wisconsin, USA, Department of Pediatrics, Division of Infectious Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36939350$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kU1v1DAQhi3Uim4LN84oR5BI8ec6OSG0allEVXoAiZs1cSa7XiX2Yidb7b-vy5YKKjjNYR4_M573lBz54JGQV4yeM8ar95udO6eUzWnJxTMyY7SuSqWYPCIzSjkvlah-nJDTlDaZknIun5MTMa9FLRSdkZslRI8pOb8qxjUW18FbyBOchb74grBl5XXseHED4_oW9kUXYrGcBvDFYj-GAVfQh52LUyoWwY8x9C_IcQd9wpcP9Yx8v7z4tliWV18_fV58vCpBsnosW-SNYAIlalSgQWrJALTSmllouEXdKJQC21YBq2qQbWOBdlJobu2cVuKMfDh4t1MzYGsxT4febKMbIO5NAGf-7ni3NquwM4wyIStBs-HNgyGGnxOm0QwuWex78BimZLiuKl1rSlVG3x5QSAM3mzBFn_-WVeY-ApMjML8iMFxk9vWfiz1u9PvmGXh3AGwMKUXsHpH_-PgT3LoRRnd_bnD9vx_dAfN7pJ0 |
| CitedBy_id | crossref_primary_10_1016_j_carbpol_2024_122101 crossref_primary_10_3390_v16091440 |
| Cites_doi | 10.1128/JVI.01861-17 10.1056/NEJM199203053261010 10.1056/NEJM199907083410203 10.1074/jbc.M111.316471 10.1016/j.molcel.2013.08.003 10.1080/15548627.2016.1248018 10.1097/TP.0000000000001418 10.1128/JVI.02015-17 10.1016/j.febslet.2014.01.045 10.1128/AAC.00214-16 10.1186/1743-422X-8-40 10.1017/s095026880005799x 10.4161/auto.5184 10.1086/315476 10.1016/j.bmc.2006.01.056 10.1128/MCB.00099-20 10.1038/s41467-020-18764-3 10.1038/s41573-018-0008-x 10.1099/vir.0.052142-0 10.1016/j.freeradbiomed.2015.06.014 10.1056/NEJMoa1706640 10.1073/pnas.1121572109 10.1073/pnas.0709695104 10.1128/JVI.05102-11 10.1128/JVI.02651-15 10.1186/s11658-016-0031-z 10.1093/clinids/13.2.315 10.1111/jop.12992 10.1074/jbc.M110.118976 10.1517/14656560802678138 10.1084/jem.20121337 10.1128/MCB.06271-11 10.1038/s41467-020-20185-1 10.1016/j.molcel.2011.07.039 10.1371/journal.pone.0007124 10.1074/jbc.M109.039925 10.1002/rmv.574 10.1016/j.bbrc.2010.12.106 10.1242/jcs.126128 10.1002/2211-5463.12385 10.1111/cbdd.13410 10.1042/EBC20170035 10.1016/j.febslet.2013.10.027 10.2174/157489107779561634 10.1038/s41598-019-41029-z 10.1128/JVI.05572-11 10.1038/s41467-019-12894-z 10.1128/CMR.00009-10 10.4084/mjhid.2019.001 10.1016/j.ophtha.2009.06.016 10.1016/j.tibs.2014.02.002 10.1128/AAC.01623-15 10.1056/NEJMoa1309533 10.1186/s12985-021-01733-7 10.1034/j.1399-3062.2001.00004.x 10.1016/j.cotox.2016.09.005 10.1128/JVI.01913-10 10.1093/infdis/jix188 10.1093/jac/45.suppl_4.29 10.18632/oncotarget.25436 10.1086/508173 10.1371/journal.ppat.1005717 10.1158/0008-5472.CAN-16-2204 10.1038/ncb2021 10.1080/15548627.2020.1732686 |
| ContentType | Journal Article |
| Copyright | Copyright © 2023 Ghosh et al. Copyright © 2023 Ghosh et al. 2023 Ghosh et al. |
| Copyright_xml | – notice: Copyright © 2023 Ghosh et al. – notice: Copyright © 2023 Ghosh et al. 2023 Ghosh et al. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1128/jvi.00160-23 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1098-5514 |
| Editor | Goodrum, Felicia |
| Editor_xml | – sequence: 1 givenname: Felicia surname: Goodrum fullname: Goodrum, Felicia |
| ExternalDocumentID | PMC10134830 00160-23 36939350 10_1128_jvi_00160_23 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R21 AI164033 – fundername: NIGMS NIH HHS grantid: R35 GM128840 – fundername: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) grantid: R21AI164033 funderid: https://doi.org/10.13039/100000060 – fundername: HHS | NIH | National Institute of General Medical Sciences (NIGMS) grantid: R35GM128840 funderid: https://doi.org/10.13039/100000057 – fundername: Children's Wisconsin Research Institute grantid: N/A – fundername: ; grantid: R21AI164033 – fundername: ; grantid: N/A – fundername: ; grantid: R35GM128840 |
| GroupedDBID | --- -~X 0R~ 18M 29L 2WC 39C 4.4 53G 5GY 5RE 5VS 85S AAFWJ AAGFI AAYXX ABPPZ ACGFO ACNCT ADBBV AENEX AGVNZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CITATION CS3 DIK E3Z EBS F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 N9A O9- OK1 P2P RHI RNS RPM RSF TR2 UPT W2D W8F WH7 WOQ YQT ~02 ~KM CGR CUY CVF ECM EIF NPM ABPTK BQPYB RHF UCJ ZA5 7X8 5PM |
| ID | FETCH-LOGICAL-a419t-de2b313e4e7e5a7a4741aa75771cab2ce7b5e43edd5a189a4dbca0f4372cc6083 |
| ISSN | 0022-538X 1098-5514 |
| IngestDate | Thu Aug 21 18:37:51 EDT 2025 Fri Jul 11 00:59:18 EDT 2025 Fri Apr 28 22:51:12 EDT 2023 Mon Jul 21 06:02:27 EDT 2025 Tue Jul 01 01:32:42 EDT 2025 Thu Apr 24 23:02:38 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | ARP101 SQSTM1/p62 p62-Keap1-Nrf2 human cytomegalovirus noncanonical Keap1-Nrf2 pathway antioxidant response element |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-a419t-de2b313e4e7e5a7a4741aa75771cab2ce7b5e43edd5a189a4dbca0f4372cc6083 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 The authors declare no conflict of interest. |
| ORCID | 0000-0002-5363-167X |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC10134830 |
| PMID | 36939350 |
| PQID | 2788797005 |
| PQPubID | 23479 |
| PageCount | 23 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10134830 proquest_miscellaneous_2788797005 asm2_journals_10_1128_jvi_00160_23 pubmed_primary_36939350 crossref_primary_10_1128_jvi_00160_23 crossref_citationtrail_10_1128_jvi_00160_23 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-04-27 |
| PublicationDateYYYYMMDD | 2023-04-27 |
| PublicationDate_xml | – month: 04 year: 2023 text: 2023-04-27 day: 27 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
| PublicationTitle | Journal of virology |
| PublicationTitleAbbrev | J Virol |
| PublicationTitleAlternate | J Virol |
| PublicationYear | 2023 |
| Publisher | American Society for Microbiology |
| Publisher_xml | – name: American Society for Microbiology |
| References | e_1_3_2_26_2 e_1_3_2_49_2 e_1_3_2_28_2 e_1_3_2_41_2 e_1_3_2_64_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_62_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_66_2 e_1_3_2_60_2 e_1_3_2_9_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_54_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_52_2 e_1_3_2_5_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_58_2 e_1_3_2_3_2 e_1_3_2_14_2 e_1_3_2_35_2 e_1_3_2_56_2 e_1_3_2_50_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_65_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_63_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_61_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_59_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_53_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_57_2 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_55_2 e_1_3_2_2_2 Sabin, CA, Devereux, HL, Clewley, G, Emery, VC, Phillips, AN, Loveday, C, Lee, CA, Griffiths, PD (B5) 2000; 181 Lamark, T, Svenning, S, Johansen, T (B29) 2017; 61 Pankiv, S, Lamark, T, Bruun, JA, Overvatn, A, Bjorkoy, G, Johansen, T (B59) 2010; 285 Camp, ND, James, RG, Dawson, DW, Yan, F, Davison, JM, Houck, SA, Tang, X, Zheng, N, Major, MB, Moon, RT (B34) 2012; 287 Schreiber, A, Harter, G, Schubert, A, Bunjes, D, Mertens, T, Michel, D (B8) 2009; 10 Watanabe, Y, Tsujimura, A, Taguchi, K, Tanaka, M (B49) 2017; 13 Katsuragi, Y, Ichimura, Y, Komatsu, M (B32) 2016; 1 Clippinger, AJ, Maguire, TG, Alwine, JC (B58) 2011; 85 Mukhopadhyay, R, Venkatadri, R, Katsnelson, J, Arav-Boger, R (B26) 2018; 92 Jain, A, Lamark, T, Sjottem, E, Larsen, KB, Awuh, JA, Overvatn, A, McMahon, M, Hayes, JD, Johansen, T (B45) 2010; 285 Zimmermann, C, Kramer, N, Krauter, S, Strand, D, Sehn, E, Wolfrum, U, Freiwald, A, Butter, F, Plachter, B (B37) 2021; 17 Kovacs, A, Schluchter, M, Easley, K, Demmler, G, Shearer, W, La, RP, Pitt, J, Cooper, E, Goldfarb, J, Hodes, D, Kattan, M, McIntosh, K (B3) 1999; 341 Taisne, C, Lussignol, M, Hernandez, E, Moris, A, Mouna, L, Esclatine, A (B38) 2019; 9 Ishimura, R, Tanaka, K, Komatsu, M (B40) 2014; 588 Chou, SW (B10) 2001; 3 Zhang, L, Wang, J, Wang, Z, Li, Y, Wang, H, Liu, H (B52) 2022; 19 Gorrini, C, Baniasadi, PS, Harris, IS, Silvester, J, Inoue, S, Snow, B, Joshi, PA, Wakeham, A, Molyneux, SD, Martin, B, Bouwman, P, Cescon, DW, Elia, AJ, Winterton-Perks, Z, Cruickshank, J, Brenner, D, Tseng, A, Musgrave, M, Berman, HK, Khokha, R, Jonkers, J, Mak, TW, Gauthier, ML (B36) 2013; 210 Kageyama, S, Gudmundsson, SR, Sou, YS, Ichimura, Y, Tamura, N, Kazuno, S, Ueno, T, Miura, Y, Noshiro, D, Abe, M, Mizushima, T, Miura, N, Okuda, S, Motohashi, H, Lee, JA, Sakimura, K, Ohe, T, Noda, NN, Waguri, S, Eskelinen, EL, Komatsu, M (B55) 2021; 12 Tsuchiya, M, Ogawa, H, Koujin, T, Mori, C, Osakada, H, Kobayashi, S, Hiraoka, Y, Haraguchi, T (B41) 2018; 8 Demmler, GJ (B6) 1991; 13 Chou, S (B16) 2008; 18 Clark, AE, Sabalza, M, Gordts, P, Spector, DH (B27) 2018; 92 Staras, SA, Dollard, SC, Radford, KW, Flanders, WD, Pass, RF, Cannon, MJ (B1) 2006; 43 Ma, J, Cai, H, Wu, T, Sobhian, B, Huo, Y, Alcivar, A, Mehta, M, Cheung, KL, Ganesan, S, Kong, AN, Zhang, DD, Xia, B (B35) 2012; 32 Desjarlais, M, Annabi, B (B23) 2019; 93 Chou, S, Ercolani, RJ, Lanier, ER (B18) 2016; 60 Taguchi, K, Fujikawa, N, Komatsu, M, Ishii, T, Unno, M, Akaike, T, Motohashi, H, Yamamoto, M (B56) 2012; 109 Jo, YK, Park, SJ, Shin, JH, Kim, Y, Hwang, JJ, Cho, DH, Kim, JC (B22) 2011; 404 Matsumoto, G, Wada, K, Okuno, M, Kurosawa, M, Nukina, N (B48) 2011; 44 Kim, ES, Jo, YK, Park, SJ, Chang, H, Shin, JH, Choi, ES, Kim, JB, Seok, SH, Kim, JS, Oh, JS, Kim, MH, Lee, EH, Cho, DH (B24) 2013; 587 Yow, MD, Demmler, GJ (B7) 1992; 326 Wyler, E, Franke, V, Menegatti, J, Kocks, C, Boltengagen, A, Praktiknjo, S, Walch-Ruckheim, B, Bosse, J, Rajewsky, N, Grasser, F, Akalin, A, Landthaler, M (B53) 2019; 10 Ghasemi, F, Black, M, Sun, RX, Vizeacoumar, F, Pinto, N, Ruicci, KM, Yoo, J, Fung, K, MacNeil, D, Palma, DA, Winquist, E, Mymryk, JS, Ailles, LA, Datti, A, Barrett, JW, Boutros, PC, Nichols, AC (B21) 2018; 9 Komatsu, M, Kurokawa, H, Waguri, S, Taguchi, K, Kobayashi, A, Ichimura, Y, Sou, YS, Ueno, I, Sakamoto, A, Tong, KI, Kim, M, Nishito, Y, Iemura, S, Natsume, T, Ueno, T, Kominami, E, Motohashi, H, Tanaka, K, Yamamoto, M (B42) 2010; 12 Chemaly, RF, Ullmann, AJ, Stoelben, S, Richard, MP, Bornhauser, M, Groth, C, Einsele, H, Silverman, M, Mullane, KM, Brown, J, Nowak, H, Kolling, K, Stobernack, HP, Lischka, P, Zimmermann, H, Rubsamen-Schaeff, H, Champlin, RE, Ehninger, G (B12) 2014; 370 Chaumorcel, M, Souquere, S, Pierron, G, Codogno, P, Esclatine, A (B44) 2008; 4 Chou, S (B17) 2015; 59 Hayes, JD, Dinkova-Kostova, AT (B31) 2014; 39 Ichimura, Y, Waguri, S, Sou, YS, Kageyama, S, Hasegawa, J, Ishimura, R, Saito, T, Yang, Y, Kouno, T, Fukutomi, T, Hoshii, T, Hirao, A, Takagi, K, Mizushima, T, Motohashi, H, Lee, MS, Yoshimori, T, Tanaka, K, Yamamoto, M, Komatsu, M (B43) 2013; 51 Lee, J, Koh, K, Kim, YE, Ahn, JH, Kim, S (B46) 2013; 94 Zhang, L, Yu, J, Pan, H, Hu, P, Hao, Y, Cai, W, Zhu, H, Yu, AD, Xie, X, Ma, D, Yuan, J (B50) 2007; 104 Griffiths, PD, Clark, DA, Emery, VC (B2) 2000; 45 Belzile, JP, Sabalza, M, Craig, M, Clark, AE, Morello, CS, Spector, DH (B25) 2016; 90 Lu, K, Alcivar, AL, Ma, J, Foo, TK, Zywea, S, Mahdi, A, Huo, Y, Kensler, TW, Gatza, ML, Xia, B (B33) 2017; 77 Jabs, DA, Martin, BK, Forman, MS (B15) 2010; 117 He, R, Sandford, G, Hayward, GS, Burns, WH, Posner, GH, Forman, M, Arav-Boger, R (B63) 2011; 8 Tilton, C, Clippinger, AJ, Maguire, T, Alwine, JC (B47) 2011; 85 Lurain, NS, Chou, S (B64) 2010; 23 Baird, L, Yamamoto, M (B30) 2020; 40 Tuccinardi, T, Martinelli, A, Nuti, E, Carelli, P, Balzano, F, Uccello-Barretta, G, Murphy, G, Rossello, A (B62) 2006; 14 Celentano, A, Yap, T, Paolini, R, Yiannis, C, Mirams, M, Koo, K, McCullough, M, Cirillo, N (B20) 2021; 50 Steininger, C (B9) 2007; 2 Avery, RK, Arav-Boger, R, Marr, KA, Kraus, E, Shoham, S, Lees, L, Trollinger, B, Shah, P, Ambinder, R, Neofytos, D, Ostrander, D, Forman, M, Valsamakis, A (B11) 2016; 100 Forman, MS, Vaidya, D, Bolorunduro, O, Diener-West, M, Pass, RF, Arav-Boger, R (B65) 2017; 215 Liu, WJ, Ye, L, Huang, WF, Guo, LJ, Xu, ZG, Wu, HL, Yang, C, Liu, HF (B28) 2016; 21 Clippinger, AJ, Maguire, TG, Alwine, JC (B57) 2011; 85 Frietsch, JJ, Michel, D, Stamminger, T, Hunstig, F, Birndt, S, Schnetzke, U, Scholl, S, Hochhaus, A, Hilgendorf, I (B14) 2019; 11 Balgi, AD, Fonseca, BD, Donohue, E, Tsang, TC, Lajoie, P, Proud, CG, Nabi, IR, Roberge, M (B51) 2009; 4 Cuadrado, A, Rojo, AI, Wells, G, Hayes, JD, Cousin, SP, Rumsey, WL, Attucks, OC, Franklin, S, Levonen, AL, Kensler, TW, Dinkova-Kostova, AT (B60) 2019; 18 Mukhopadhyay, R, Roy, S, Venkatadri, R, Su, YP, Ye, W, Barnaeva, E, Mathews Griner, L, Southall, N, Hu, X, Wang, AQ, Xu, X, Dulcey, AE, Marugan, JJ, Ferrer, M, Arav-Boger, R (B19) 2016; 12 Sabin, CA, Phillips, AN, Lee, CA, Janossy, G, Emery, V, Griffiths, PD (B4) 1995; 114 Marty, FM, Ljungman, P, Chemaly, RF, Maertens, J, Dadwal, SS, Duarte, RF, Haider, S, Ullmann, AJ, Katayama, Y, Brown, J, Mullane, KM, Boeckh, M, Blumberg, EA, Einsele, H, Snydman, DR, Kanda, Y, DiNubile, MJ, Teal, VL, Wan, H, Murata, Y, Kartsonis, NA, Leavitt, RY, Badshah, C (B13) 2017; 377 Birgisdottir, AB, Lamark, T, Johansen, T (B39) 2013; 126 Jiang, T, Harder, B, Rojo de la Vega, M, Wong, PK, Chapman, E, Zhang, DD (B54) 2015; 88 Olagnier, D, Farahani, E, Thyrsted, J, Blay-Cadanet, J, Herengt, A, Idorn, M, Hait, A, Hernaez, B, Knudsen, A, Iversen, MB, Schilling, M, Jorgensen, SE, Thomsen, M, Reinert, LS, Lappe, M, Hoang, HD, Gilchrist, VH, Hansen, AL, Ottosen, R, Nielsen, CG, Moller, C, van der Horst, D, Peri, S, Balachandran, S, Huang, J, Jakobsen, M, Svenningsen, EB, Poulsen, TB, Bartsch, L, Thielke, AL, Luo, Y, Alain, T, Rehwinkel, J, Alcami, A, Hiscott, J, Mogensen, TH, Paludan, SR, Holm, CK (B61) 2020; 11 |
| References_xml | – ident: e_1_3_2_27_2 doi: 10.1128/JVI.01861-17 – ident: e_1_3_2_8_2 doi: 10.1056/NEJM199203053261010 – ident: e_1_3_2_4_2 doi: 10.1056/NEJM199907083410203 – ident: e_1_3_2_35_2 doi: 10.1074/jbc.M111.316471 – ident: e_1_3_2_44_2 doi: 10.1016/j.molcel.2013.08.003 – ident: e_1_3_2_50_2 doi: 10.1080/15548627.2016.1248018 – ident: e_1_3_2_12_2 doi: 10.1097/TP.0000000000001418 – ident: e_1_3_2_28_2 doi: 10.1128/JVI.02015-17 – ident: e_1_3_2_41_2 doi: 10.1016/j.febslet.2014.01.045 – ident: e_1_3_2_19_2 doi: 10.1128/AAC.00214-16 – ident: e_1_3_2_64_2 doi: 10.1186/1743-422X-8-40 – ident: e_1_3_2_5_2 doi: 10.1017/s095026880005799x – ident: e_1_3_2_45_2 doi: 10.4161/auto.5184 – ident: e_1_3_2_6_2 doi: 10.1086/315476 – ident: e_1_3_2_63_2 doi: 10.1016/j.bmc.2006.01.056 – ident: e_1_3_2_31_2 doi: 10.1128/MCB.00099-20 – ident: e_1_3_2_62_2 doi: 10.1038/s41467-020-18764-3 – ident: e_1_3_2_61_2 doi: 10.1038/s41573-018-0008-x – ident: e_1_3_2_47_2 doi: 10.1099/vir.0.052142-0 – ident: e_1_3_2_55_2 doi: 10.1016/j.freeradbiomed.2015.06.014 – ident: e_1_3_2_14_2 doi: 10.1056/NEJMoa1706640 – ident: e_1_3_2_57_2 doi: 10.1073/pnas.1121572109 – ident: e_1_3_2_51_2 doi: 10.1073/pnas.0709695104 – ident: e_1_3_2_59_2 doi: 10.1128/JVI.05102-11 – ident: e_1_3_2_26_2 doi: 10.1128/JVI.02651-15 – ident: e_1_3_2_29_2 doi: 10.1186/s11658-016-0031-z – ident: e_1_3_2_7_2 doi: 10.1093/clinids/13.2.315 – ident: e_1_3_2_21_2 doi: 10.1111/jop.12992 – ident: e_1_3_2_46_2 doi: 10.1074/jbc.M110.118976 – ident: e_1_3_2_9_2 doi: 10.1517/14656560802678138 – ident: e_1_3_2_37_2 doi: 10.1084/jem.20121337 – ident: e_1_3_2_36_2 doi: 10.1128/MCB.06271-11 – ident: e_1_3_2_56_2 doi: 10.1038/s41467-020-20185-1 – ident: e_1_3_2_49_2 doi: 10.1016/j.molcel.2011.07.039 – ident: e_1_3_2_52_2 doi: 10.1371/journal.pone.0007124 – ident: e_1_3_2_60_2 doi: 10.1074/jbc.M109.039925 – ident: e_1_3_2_17_2 doi: 10.1002/rmv.574 – ident: e_1_3_2_23_2 doi: 10.1016/j.bbrc.2010.12.106 – ident: e_1_3_2_40_2 doi: 10.1242/jcs.126128 – ident: e_1_3_2_42_2 doi: 10.1002/2211-5463.12385 – ident: e_1_3_2_24_2 doi: 10.1111/cbdd.13410 – ident: e_1_3_2_30_2 doi: 10.1042/EBC20170035 – ident: e_1_3_2_25_2 doi: 10.1016/j.febslet.2013.10.027 – ident: e_1_3_2_10_2 doi: 10.2174/157489107779561634 – ident: e_1_3_2_39_2 doi: 10.1038/s41598-019-41029-z – ident: e_1_3_2_48_2 doi: 10.1128/JVI.05572-11 – ident: e_1_3_2_54_2 doi: 10.1038/s41467-019-12894-z – ident: e_1_3_2_65_2 doi: 10.1128/CMR.00009-10 – ident: e_1_3_2_15_2 doi: 10.4084/mjhid.2019.001 – ident: e_1_3_2_16_2 doi: 10.1016/j.ophtha.2009.06.016 – ident: e_1_3_2_32_2 doi: 10.1016/j.tibs.2014.02.002 – ident: e_1_3_2_18_2 doi: 10.1128/AAC.01623-15 – ident: e_1_3_2_13_2 doi: 10.1056/NEJMoa1309533 – ident: e_1_3_2_53_2 doi: 10.1186/s12985-021-01733-7 – ident: e_1_3_2_11_2 doi: 10.1034/j.1399-3062.2001.00004.x – ident: e_1_3_2_33_2 doi: 10.1016/j.cotox.2016.09.005 – ident: e_1_3_2_58_2 doi: 10.1128/JVI.01913-10 – ident: e_1_3_2_66_2 doi: 10.1093/infdis/jix188 – ident: e_1_3_2_3_2 doi: 10.1093/jac/45.suppl_4.29 – ident: e_1_3_2_22_2 doi: 10.18632/oncotarget.25436 – ident: e_1_3_2_2_2 doi: 10.1086/508173 – ident: e_1_3_2_20_2 doi: 10.1371/journal.ppat.1005717 – ident: e_1_3_2_34_2 doi: 10.1158/0008-5472.CAN-16-2204 – ident: e_1_3_2_43_2 doi: 10.1038/ncb2021 – ident: e_1_3_2_38_2 doi: 10.1080/15548627.2020.1732686 – volume: 61 start-page: 609 year: 2017 end-page: 624 ident: B29 article-title: Regulation of selective autophagy: the p62/SQSTM1 paradigm publication-title: Essays Biochem doi: 10.1042/EBC20170035 – volume: 40 year: 2020 ident: B30 article-title: The molecular mechanisms regulating the KEAP1-NRF2 pathway publication-title: Mol Cell Biol doi: 10.1128/MCB.00099-20 – volume: 10 start-page: 4878 year: 2019 ident: B53 article-title: Single-cell RNA-sequencing of herpes simplex virus 1-infected cells connects NRF2 activation to an antiviral program publication-title: Nat Commun doi: 10.1038/s41467-019-12894-z – volume: 285 start-page: 5941 year: 2010 end-page: 5953 ident: B59 article-title: Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies publication-title: J Biol Chem doi: 10.1074/jbc.M109.039925 – volume: 587 start-page: 3955 year: 2013 end-page: 3960 ident: B24 article-title: ARP101 inhibits alpha-MSH-stimulated melanogenesis by regulation of autophagy in melanocytes publication-title: FEBS Lett doi: 10.1016/j.febslet.2013.10.027 – volume: 12 start-page: 16 year: 2021 ident: B55 article-title: p62/SQSTM1-droplet serves as a platform for autophagosome formation and anti-oxidative stress response publication-title: Nat Commun doi: 10.1038/s41467-020-20185-1 – volume: 287 start-page: 6539 year: 2012 end-page: 6550 ident: B34 article-title: Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein publication-title: J Biol Chem doi: 10.1074/jbc.M111.316471 – volume: 88 start-page: 199 year: 2015 end-page: 204 ident: B54 article-title: p62 links autophagy and Nrf2 signaling publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2015.06.014 – volume: 2 start-page: 53 year: 2007 end-page: 72 ident: B9 article-title: Novel therapies for cytomegalovirus disease publication-title: Recent Pat Antiinfect Drug Discov doi: 10.2174/157489107779561634 – volume: 285 start-page: 22576 year: 2010 end-page: 22591 ident: B45 article-title: p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription publication-title: J Biol Chem doi: 10.1074/jbc.M110.118976 – volume: 210 start-page: 1529 year: 2013 end-page: 1544 ident: B36 article-title: BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival publication-title: J Exp Med doi: 10.1084/jem.20121337 – volume: 588 start-page: 822 year: 2014 end-page: 828 ident: B40 article-title: Dissection of the role of p62/Sqstm1 in activation of Nrf2 during xenophagy publication-title: FEBS Lett doi: 10.1016/j.febslet.2014.01.045 – volume: 11 year: 2019 ident: B14 article-title: In vivo emergence of UL56 C325Y cytomegalovirus resistance to letermovir in a patient with acute myeloid leukemia after hematopoietic cell transplantation publication-title: Mediterr J Hematol Infect Dis doi: 10.4084/mjhid.2019.001 – volume: 51 start-page: 618 year: 2013 end-page: 631 ident: B43 article-title: Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy publication-title: Mol Cell doi: 10.1016/j.molcel.2013.08.003 – volume: 50 start-page: 323 year: 2021 end-page: 332 ident: B20 article-title: Inhibition of matrix metalloproteinase-2 modulates malignant behaviour of oral squamous cell carcinoma cells publication-title: J Oral Pathol Med doi: 10.1111/jop.12992 – volume: 45 start-page: 29 year: 2000 end-page: 34 ident: B2 article-title: Betaherpesviruses in transplant recipients publication-title: J Antimicrob Chemother doi: 10.1093/jac/45.suppl_4.29 – volume: 39 start-page: 199 year: 2014 end-page: 218 ident: B31 article-title: The Nrf2 regulatory network provides an interface between redox and intermediary metabolism publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2014.02.002 – volume: 114 start-page: 361 year: 1995 end-page: 372 ident: B4 article-title: The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion publication-title: Epidemiol Infect doi: 10.1017/s095026880005799x – volume: 181 start-page: 1800 year: 2000 end-page: 1803 ident: B5 article-title: Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia publication-title: J Infect Dis doi: 10.1086/315476 – volume: 9 start-page: 26064 year: 2018 end-page: 26071 ident: B21 article-title: High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines publication-title: Oncotarget doi: 10.18632/oncotarget.25436 – volume: 341 start-page: 77 year: 1999 end-page: 84 ident: B3 article-title: Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group publication-title: N Engl J Med doi: 10.1056/NEJM199907083410203 – volume: 377 start-page: 2433 year: 2017 end-page: 2444 ident: B13 article-title: Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation publication-title: N Engl J Med doi: 10.1056/NEJMoa1706640 – volume: 12 year: 2016 ident: B19 article-title: Efficacy and mechanism of action of low dose emetine against human cytomegalovirus publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1005717 – volume: 92 year: 2018 ident: B26 article-title: Digitoxin suppresses human cytomegalovirus replication via Na(+), K(+)/ATPase alpha1 subunit-dependent AMP-activated protein kinase and autophagy activation publication-title: J Virol doi: 10.1128/JVI.01861-17 – volume: 11 start-page: 4938 year: 2020 ident: B61 article-title: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate publication-title: Nat Commun doi: 10.1038/s41467-020-18764-3 – volume: 1 start-page: 54 year: 2016 end-page: 61 ident: B32 article-title: Regulation of the Keap1–Nrf2 pathway by p62/SQSTM1 publication-title: Curr Opin Toxicol doi: 10.1016/j.cotox.2016.09.005 – volume: 104 start-page: 19023 year: 2007 end-page: 19028 ident: B50 article-title: Small molecule regulators of autophagy identified by an image-based high-throughput screen publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0709695104 – volume: 100 start-page: e74 year: 2016 end-page: e80 ident: B11 article-title: Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory cytomegalovirus infection publication-title: Transplantation doi: 10.1097/TP.0000000000001418 – volume: 215 start-page: 1523 year: 2017 end-page: 1526 ident: B65 article-title: Cytomegalovirus kinetics following primary infection in healthy women publication-title: J Infect Dis doi: 10.1093/infdis/jix188 – volume: 404 start-page: 1039 year: 2011 end-page: 1043 ident: B22 article-title: ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2010.12.106 – volume: 326 start-page: 702 year: 1992 end-page: 703 ident: B7 article-title: Congenital cytomegalovirus disease–20 years is long enough publication-title: N Engl J Med doi: 10.1056/NEJM199203053261010 – volume: 18 start-page: 233 year: 2008 end-page: 246 ident: B16 article-title: Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir publication-title: Rev Med Virol doi: 10.1002/rmv.574 – volume: 14 start-page: 4260 year: 2006 end-page: 4276 ident: B62 article-title: Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2006.01.056 – volume: 59 start-page: 6588 year: 2015 end-page: 6593 ident: B17 article-title: Rapid in vitro evolution of human cytomegalovirus UL56 mutations that confer letermovir resistance publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01623-15 – volume: 13 start-page: 315 year: 1991 end-page: 329 ident: B6 article-title: Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease publication-title: Rev Infect Dis doi: 10.1093/clinids/13.2.315 – volume: 19 start-page: 23 year: 2022 ident: B52 article-title: Upregulation of nuclear factor E2-related factor 2 (Nrf2) represses the replication of herpes simplex virus type 1 publication-title: Virol J doi: 10.1186/s12985-021-01733-7 – volume: 43 start-page: 1143 year: 2006 end-page: 1151 ident: B1 article-title: Seroprevalence of cytomegalovirus infection in the United States, 1988–1994 publication-title: Clin Infect Dis doi: 10.1086/508173 – volume: 8 start-page: 470 year: 2018 end-page: 480 ident: B41 article-title: p62/SQSTM1 promotes rapid ubiquitin conjugation to target proteins after endosome rupture during xenophagy publication-title: FEBS Open Bio doi: 10.1002/2211-5463.12385 – volume: 3 start-page: 20 year: 2001 end-page: 24 ident: B10 article-title: Cytomegalovirus drug resistance and clinical implications publication-title: Transpl Infect Dis doi: 10.1034/j.1399-3062.2001.00004.x – volume: 92 year: 2018 ident: B27 article-title: Human cytomegalovirus replication is inhibited by the autophagy-inducing compounds trehalose and SMER28 through distinctively different mechanisms publication-title: J Virol doi: 10.1128/JVI.02015-17 – volume: 370 start-page: 1781 year: 2014 end-page: 1789 ident: B12 article-title: Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation publication-title: N Engl J Med doi: 10.1056/NEJMoa1309533 – volume: 93 start-page: 272 year: 2019 end-page: 282 ident: B23 article-title: Dual functions of ARP101 in targeting membrane type-1 matrix metalloproteinase: impact on U87 glioblastoma cell invasion and autophagy signaling publication-title: Chem Biol Drug Des doi: 10.1111/cbdd.13410 – volume: 117 start-page: 128 year: 2010 end-page: 132.e2 ident: B15 article-title: Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS publication-title: Ophthalmology doi: 10.1016/j.ophtha.2009.06.016 – volume: 60 start-page: 3845 year: 2016 end-page: 3848 ident: B18 article-title: Novel cytomegalovirus UL54 DNA polymerase gene mutations selected in vitro that confer brincidofovir resistance publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00214-16 – volume: 32 start-page: 1506 year: 2012 end-page: 1517 ident: B35 article-title: PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function publication-title: Mol Cell Biol doi: 10.1128/MCB.06271-11 – volume: 44 start-page: 279 year: 2011 end-page: 289 ident: B48 article-title: Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins publication-title: Mol Cell doi: 10.1016/j.molcel.2011.07.039 – volume: 85 start-page: 3930 year: 2011 end-page: 3939 ident: B57 article-title: The changing role of mTOR kinase in the maintenance of protein synthesis during human cytomegalovirus infection publication-title: J Virol doi: 10.1128/JVI.01913-10 – volume: 8 start-page: 40 year: 2011 ident: B63 article-title: Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors publication-title: Virol J doi: 10.1186/1743-422X-8-40 – volume: 4 year: 2009 ident: B51 article-title: Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling publication-title: PLoS One doi: 10.1371/journal.pone.0007124 – volume: 21 start-page: 29 year: 2016 ident: B28 article-title: p62 links the autophagy pathway and the ubiquitin-proteasome system upon ubiquitinated protein degradation publication-title: Cell Mol Biol Lett doi: 10.1186/s11658-016-0031-z – volume: 9 start-page: 4560 year: 2019 ident: B38 article-title: Human cytomegalovirus hijacks the autophagic machinery and LC3 homologs in order to optimize cytoplasmic envelopment of mature infectious particles publication-title: Sci Rep doi: 10.1038/s41598-019-41029-z – volume: 18 start-page: 295 year: 2019 end-page: 317 ident: B60 article-title: Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases publication-title: Nat Rev Drug Discov doi: 10.1038/s41573-018-0008-x – volume: 90 start-page: 1259 year: 2016 end-page: 1277 ident: B25 article-title: Trehalose, an mTOR-independent inducer of autophagy, inhibits human cytomegalovirus infection in multiple cell types publication-title: J Virol doi: 10.1128/JVI.02651-15 – volume: 4 start-page: 46 year: 2008 end-page: 53 ident: B44 article-title: Human cytomegalovirus controls a new autophagy-dependent cellular antiviral defense mechanism publication-title: Autophagy doi: 10.4161/auto.5184 – volume: 85 start-page: 12585 year: 2011 end-page: 12593 ident: B47 article-title: Human cytomegalovirus induces multiple means to combat reactive oxygen species publication-title: J Virol doi: 10.1128/JVI.05572-11 – volume: 17 start-page: 779 year: 2021 end-page: 795 ident: B37 article-title: Autophagy interferes with human cytomegalovirus genome replication, morphogenesis, and progeny release publication-title: Autophagy doi: 10.1080/15548627.2020.1732686 – volume: 77 start-page: 2881 year: 2017 end-page: 2892 ident: B33 article-title: NRF2 induction supporting breast cancer cell survival is enabled by oxidative stress-induced DPP3-KEAP1 interaction publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-16-2204 – volume: 85 start-page: 9369 year: 2011 end-page: 9376 ident: B58 article-title: Human cytomegalovirus infection maintains mTOR activity and its perinuclear localization during amino acid deprivation publication-title: J Virol doi: 10.1128/JVI.05102-11 – volume: 23 start-page: 689 year: 2010 end-page: 712 ident: B64 article-title: Antiviral drug resistance of human cytomegalovirus publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00009-10 – volume: 109 start-page: 13561 year: 2012 end-page: 13566 ident: B56 article-title: Keap1 degradation by autophagy for the maintenance of redox homeostasis publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1121572109 – volume: 10 start-page: 191 year: 2009 end-page: 209 ident: B8 article-title: Antiviral treatment of cytomegalovirus infection and resistant strains publication-title: Expert Opin Pharmacother doi: 10.1517/14656560802678138 – volume: 12 start-page: 213 year: 2010 end-page: 223 ident: B42 article-title: The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 publication-title: Nat Cell Biol doi: 10.1038/ncb2021 – volume: 13 start-page: 133 year: 2017 end-page: 148 ident: B49 article-title: HSF1 stress response pathway regulates autophagy receptor SQSTM1/p62-associated proteostasis publication-title: Autophagy doi: 10.1080/15548627.2016.1248018 – volume: 126 start-page: 3237 year: 2013 end-page: 3247 ident: B39 article-title: The LIR motif - crucial for selective autophagy publication-title: J Cell Sci doi: 10.1242/jcs.126128 – volume: 94 start-page: 1658 year: 2013 end-page: 1668 ident: B46 article-title: Upregulation of Nrf2 expression by human cytomegalovirus infection protects host cells from oxidative stress publication-title: J Gen Virol doi: 10.1099/vir.0.052142-0 |
| SSID | ssj0014464 |
| Score | 2.4301486 |
| Snippet | Antiviral treatment for human cytomegalovirus (HCMV) is limited and suffers from the selection of drug-resistant viruses. Several cellular pathways have been... Host-derived cellular pathways can provide an unfavorable environment for virus replication. These pathways have been a subject of interest for herpesviruses,... |
| SourceID | pubmedcentral proquest asm2 pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0016023 |
| SubjectTerms | Antimicrobial Chemotherapy Antioxidant Response Elements - drug effects Antiviral Agents - pharmacology Cell Line Cellular Response to Infection Cytomegalovirus - drug effects Cytomegalovirus - physiology Cytomegalovirus Infections - prevention & control Cytomegalovirus Infections - virology Humans Phosphorylation - drug effects Transcription, Genetic - drug effects Virus Replication |
| Title | Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36939350 https://journals.asm.org/doi/10.1128/jvi.00160-23 https://www.proquest.com/docview/2788797005 https://pubmed.ncbi.nlm.nih.gov/PMC10134830 |
| Volume | 97 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9owELboVq32UvVd-lJatadVKDjOw8cVKou6AnHYlbhFTmxEqkIQhK3opX-9M3YehrJSu5cIJSaJ5vsynrHnQcgnmKGVmEXK5QJ8EzbjoAdF2HUTie6ICHiSYL7zaBwMr9m3qT9ttX5bUUvbIumkv47mldwFVTgHuGKW7H8gW98UTsBvwBeOgDAc_wnjoVijpqoynsb5EgSVm0zHSyVWPXe8nlEswz__KUxkplm07--KfKFgcshvsvVWt-0sTODHMUsVU-HsxfeLeb7RqzHnO7jXZafZWNIKfetOsppyA52VcBigrzX8zmgoE9t9NujYCxDUw70Uk89vxfyjMrLCTEdZU0bKVr_o-Xq6lzBMPkbjYkFTNNtslWxCdkvqseOanmL2wvebrKNbZbsma9kCfbXQqHsBx-zjbjPf1VGIk1EfFJLHIq97j9yn4GdgC4yLaR0jhL4yq8rN43tXmRM0-mI_-ZQ8rB4DM7vYLOi-lfOX63IYgWuZNFePyaMSYefcEOsJaanlU_LAdCfdPSOThl4O0Mux6eU09HJKejmAiKPp5RzQyynp9ZxcD75e9Ydu2YDDFazHC1cqmng9TzEVKl-EgoH5KUToh2EvFQlNVZj4inlKSl_0Ii6YTFLRneFWcJoGYNy_ICfwWuoVcbifwkAuIwkiDaQUHEzrUArph2mSMt4mH1Fucfl1bWLtnNIoBjnHWs4x9drkrJJqnJYl7LGTyo9bRn-uR69M6ZZbxn2oAIpBt-KGmViqfLuJKYba8hAmqjZ5aQCr71QB3ibRHpT1AKzbvn9lmc11_faKdK_v_tc35LT5FN-Sk2K9Ve_AOi6S95rBfwC5_Lx1 |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Harnessing+the+Noncanonical+Keap1-Nrf2+Pathway+for+Human+Cytomegalovirus+Control&rft.jtitle=Journal+of+virology&rft.au=Ghosh%2C+Ayan+K.&rft.au=Su%2C+Yu-Pin&rft.au=Forman%2C+Michael&rft.au=Keyes%2C+Robert+F.&rft.date=2023-04-27&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=97&rft.issue=4&rft_id=info:doi/10.1128%2Fjvi.00160-23&rft_id=info%3Apmid%2F36939350&rft.externalDocID=PMC10134830 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |